期刊文献+

高压氧综合治疗溃疡性结肠炎的疗效观察 被引量:12

Effect of comprehensive hyperbaric oxygen on ulcerative colitis
原文传递
导出
摘要 目的观察高压氧(hyperbaric oxygen,HBO)联合柳氮磺胺吡啶治疗溃疡性结肠炎的疗效,探讨治疗溃疡性结肠炎安全有效的方法。方法经患者知情同意,276例溃疡性结肠炎患者分为对照组(135例)和HBO治疗组(HBO组,141例)。对照组口服柳氮磺胺吡啶;HBO组除口服柳氮磺胺吡啶外,另给予HBO治疗;2组均治疗8周。分别于治疗第2、4、8周观察2组的临床症状及内镜外观改善情况。结果HBO组显效率、总有效率分别为84.4%和100.0%,明显高于对照组的44.4%及76.3%,2组比较差异有统计学意义(P〈0.05)。结论HBO联合柳氮磺胺吡啶治疗溃疡性结肠炎疗效迅速、显著,不良反应少。 Objective To observe the effect of hyperbaric oxygen (HBO) coupled with sulfasalazine on ulcerative colitis, and to investigate safe and effective methods for the treatment of ulcerative colitis. Methods Two hundred and seventy-six cases of ulcerative colitis were randomly divided into the control group receiving only sulfasalazine (135 cases) for 8 weeks and the HBO group (141 cases) treated with HBO combined with sulfasalazine for 8 weeks. Observations were made on the improvement of clinical symptoms and outward appearance under the endoscope in the 2nd, 4th and 8th weeks respectively. Results Significant effective rate and total effective rate for the HBO group accounted for 84. 4% and 100%, which were significantly higher than those of the control group (44.4% and 76.3% ). There were statistical significance between the two group (P 〈 0. 05 ). Conclusions HB0 coupled with sulfasalazine in the treatment of ulcerative colitis could produce quicker and more significant results, and with fewer side-effects.
作者 杨金华 王钢
出处 《中华航海医学与高气压医学杂志》 CAS CSCD 北大核心 2012年第4期224-226,共3页 Chinese Journal of Nautical Medicine and Hyperbaric Medicine
关键词 高压氧 柳氮磺胺吡啶 综合治疗 溃疡性结肠炎 Hyperbaric oxygen Sulfasalazine Comprehensive treatment Ulcerative Colitis
  • 相关文献

参考文献6

二级参考文献41

  • 1周长玉,王江滨.益生菌治疗炎症性肠病及其作用机制[J].国外医学(内科学分册),2004,31(11):489-491. 被引量:4
  • 2霍丽娟,赵和平,侯晓华.双岐三联活菌对实验性结肠炎大鼠结肠黏膜细胞因子表达的影响[J].中华消化杂志,2005,25(8):501-502. 被引量:7
  • 3冯百岁,刘占举,牛正先.美沙拉秦治疗溃疡性结肠炎的临床疗效及对血清TNF-α和IL-8的影响[J].郑州大学学报(医学版),2006,41(5):830-833. 被引量:40
  • 4潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 5潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 6Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol, 2000, 95(1 Suppl):S19-S21. 被引量:1
  • 7Qureshi AI, Cohen RD. Mesalamine delivery systems, do they really make much difference? Adv Drug Deliv Rev, 2005, 57:281-302. 被引量:1
  • 8Green JR, Lobo AJ, Holdsworth CD, et al. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology, 1998, 114 : 15-22. 被引量:1
  • 9Pruitt R, Hanson J, Safdi M,et al. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis. Am J Gastroenterol, 2002, 97:3078-3086. 被引量:1
  • 10Sandborn W J, Hanauer SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine prodrugs used in the management of ulcerative colitis. Aliment Pharmacol Ther, 2003, 17:29-42. 被引量:1

共引文献1500

同被引文献126

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部